BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21663568)

  • 21. Monitoring of mycophenolate acid in serum or plasma using LC tandem mass spectrometry.
    Hammett-Stabler CA; Geis DC; Ritchie JC; Papadea C
    Methods Mol Biol; 2010; 603():379-87. PubMed ID: 20077090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification by liquid chromatography tandem mass spectrometry of mycophenolic acid and its phenol and acyl glucuronide metabolites.
    Brandhorst G; Streit F; Goetze S; Oellerich M; Armstrong VW
    Clin Chem; 2006 Oct; 52(10):1962-4. PubMed ID: 16931568
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Everolimus method comparison between Waters MassTrak™ Immunosuppressants XE (IUO) kit and an in-house laboratory developed LC-MS/MS method in renal transplant patients.
    Johnson-Davis KL; Juenke JM; Thomas RL; Bradshaw T
    Ann Clin Lab Sci; 2015; 45(1):27-31. PubMed ID: 25696007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous quantification of mycophenolic acid and its glucuronide metabolites in human plasma by an UPLC-MS/MS assay.
    Zhang D; Chow DS; Renbarger JL
    Biomed Chromatogr; 2016 Oct; 30(10):1648-55. PubMed ID: 27061819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput LC-MS/MS method for monitoring sirolimus and everolimus in the routine clinical laboratory.
    Ivanova M; Artusi C; Polo G; Zaninotto M; Plebani M
    Clin Chem Lab Med; 2011 Jul; 49(7):1151-8. PubMed ID: 21574883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validated LC-MS/MS method for quantitation of total and free mycophenolic acid concentration and its application to a pharmacokinetic study in pediatric renal transplant recipients.
    Liu Y; Liu L; Li J; Fu Q; Zhang H; Wu C; Li J; Zhong G; Zheng Y; Chen X; Wang C; Chen P
    Biomed Chromatogr; 2021 Feb; 35(2):e4989. PubMed ID: 32959916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Drug Monitoring of Everolimus: Comparability of Concentrations Determined by 2 Immunoassays and a Liquid Chromatography Tandem Mass Spectrometry Method.
    Shipkova M; Rapp S; Rigo-Bonnin R; Wieland E; Peter A
    Ther Drug Monit; 2017 Apr; 39(2):102-108. PubMed ID: 28125504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of a new enzymatic assay with a high-performance liquid chromatography/ ultraviolet detection method for therapeutic drug monitoring of mycophenolic acid in adult liver transplant recipients.
    Blanchet B; Taieb F; Conti F; Abbas H; Seydi I; Harcouet L; Dauphin A; Calmus Y; Tod M
    Liver Transpl; 2008 Dec; 14(12):1745-51. PubMed ID: 19025918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a sensitive liquid-chromatography tandem mass spectrometry assay for mycophenolic acid and metabolites in HepaRG cell culture: Characterization of metabolism interactions between p-cresol and mycophenolic acid.
    Rong Y; Kiang TKL
    Biomed Chromatogr; 2019 Aug; 33(8):e4549. PubMed ID: 30958902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of concordance between EMIT assay and LC-MS/MS for Therapeutic Drug Monitoring of Mycophenolic Acid: Potential increased risk for graft rejection?
    De Nicolò A; Ianniello A; Benagli C; Della Bruna R; Keller F; Antonucci M; D'Avolio A; Cantù M
    J Pharm Biomed Anal; 2020 Aug; 187():113337. PubMed ID: 32442868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous determination of cortisol, dexamethasone, methylprednisolone, prednisone, prednisolone, mycophenolic acid and mycophenolic acid glucuronide in human plasma utilizing liquid chromatography-tandem mass spectrometry.
    Difrancesco R; Frerichs V; Donnelly J; Hagler C; Hochreiter J; Tornatore KM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(1):42-51. PubMed ID: 17928278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UPLC MS/MS method for quantification of mycophenolic acid and metabolites in human plasma: Application to pharmacokinetic study.
    Delavenne X; Juthier L; Pons B; Mariat C; Basset T
    Clin Chim Acta; 2011 Jan; 412(1-2):59-65. PubMed ID: 20937266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients.
    Ham JY; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD; Won DI; Song KE; Cho JH
    Scand J Clin Lab Invest; 2016 Jul; 76(4):296-303. PubMed ID: 26981890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipients.
    Laverdière I; Caron P; Couture F; Lévesque E; Guillemette C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():131-7. PubMed ID: 22265668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical and clinical performance of the new Fujirebio 25-OH vitamin D assay, a comparison with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and three other automated assays.
    Saleh L; Mueller D; von Eckardstein A
    Clin Chem Lab Med; 2016 Apr; 54(4):617-25. PubMed ID: 26457778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitation of Mycophenolic Acid and Mycophenolic Acid Glucuronide in Serum or Plasma by LC-MS/MS.
    Garg U; Munar A; Frazee C
    Curr Protoc; 2023 Apr; 3(4):e730. PubMed ID: 37039714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inclusion of MPA and in a rapid multi-drug LC-tandem mass spectrometric method for simultaneous determination of immunosuppressants.
    Ceglarek U; Casetta B; Lembcke J; Baumann S; Fiedler GM; Thiery J
    Clin Chim Acta; 2006 Nov; 373(1-2):168-71. PubMed ID: 16806142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter evaluation of a new inosine monophosphate dehydrogenase inhibition assay for quantification of total mycophenolic acid in plasma.
    Brandhorst G; Marquet P; Shaw LM; Liebisch G; Schmitz G; Coffing MJ; Domke I; Streit F; Luthe H; Oellerich M
    Ther Drug Monit; 2008 Aug; 30(4):428-33. PubMed ID: 18641549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic drug monitoring on COBAS INTEGRA 400--evaluation results.
    Domke I; Cremer P; Huchtemann M
    Clin Lab; 2000; 46(9-10):509-15. PubMed ID: 11034537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS.
    Meunier C; Blondelle D; Faure P; Baguet JP; Le Goff C; Chabre O; Ducros V
    Clin Chim Acta; 2015 Jul; 447():8-15. PubMed ID: 25982778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.